ClinicalTrials.gg
RecruitingNCT07669246Updated Jul 2, 2026

Interoception in Stroke

An observational study in Stroke, sponsored by Istinye University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by Istinye University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Stroke by Istinye University — 5 open to participants now, 5 under way, none of them phase 3. Stroke · Istinye University.

Started
2026
with 3 others
Observational
4 of 13
4 open now
Registered
11th of 13
by date

Among the 13 studies in Stroke by Istinye University, this one is one of 4 that started in 2026, is one of 4 observational ones, and was the 11th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

5 of the 13 studies in Stroke by Istinye University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke by Istinye University, or all of them as a file.
02

Study summary

This study aims to examine the associations of interoceptive awareness and interoceptive accuracy with plantar superficial sensory threshold, knee joint proprioception, pain intensity, and dynamic balance performance in cognitively intact individuals with chronic hemiplegia.

Hypotheses are:

  • H0: There is no significant relationship between interoception and light touch, proprioception, pain, or dynamic balance performance in cognitively intact individuals with chronic hemiplegia.
  • H1: There is a significant relationship between interoception and light touch, proprioception, pain, or dynamic balance performance in cognitively intact individuals with chronic hemiplegia All participants will undergo a single assessment session and will not be invited for any treatment or follow-up evaluation. Participants will not take any intervention.
Read the detailed description

Participants will not take any intervention.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Plantar sensation
  • Joint position sense
  • Fear of falling
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Outpatient stroke patients from a university hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of hemiplegia due to a physician-diagnosed stroke,
  • At least 6 months have passed since the stroke,
  • Voluntary agreement to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • History of traumatic brain injury, brain tumor, meningitis, or secondary neurological disease,
  • Having experienced a cardiovascular event or any acute medical condition within the last 3 months,
  • Insufficient visual or auditory ability to understand the questionnaires and tests.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Interoceptive Awareness

    The Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2) consists of eight subscales, each scored from 0 to 5. Higher scores indicate greater interoceptive awareness in the corresponding domain.

    Time frame: Day 1

  2. Interoceptive Accuracy

    Heartbeat Counting Task

    Time frame: Day 1

  3. Proprioception Assessment

    Joint Position Reconstruction Test for the 45 degrees knee flexion.

    Time frame: Day 1

  4. Functional Mobility and Balance

    Timed-up and Go Test

    Time frame: Day 1

  5. Functional Lower Extremity Strength

    5 Times Sit-to-Stand Test

    Time frame: Day 1

Secondary outcomes

  1. Light Touch Sensation

    Semmes-Weinstein Monofilament Test on the plantar surface of the foot

    Time frame: Day 1

  2. Subjective Pain

    The Numeric Rating Scale for Lower Extremity Pain Severity is an 11-point scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate greater pain severity.

    Time frame: Day 1

  3. Fear of Falling

    The Falls Efficacy Scale-International (FES-I) consists of 16 items, with a total score ranging from 16 to 64. Higher scores indicate greater concern about falling (greater fear of falling).

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Liv Hospital Topkapi
    Istanbul, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Dec 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2026
First posted
Jun 25, 2026
StartEst.
Jun 20, 2026
Primary completionEst.
Dec 25, 2026
CompletionEst.
Dec 25, 2026
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07669246
Lead sponsor
Istinye University
Responsible party
Çiçek Günday (Asst. Prof, Istinye University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jun 20, 2026 (estimated)
Primary completion
Dec 25, 2026 (estimated)
Completion
Dec 25, 2026 (estimated)
Last update
Jul 2, 2026

Study contacts

Çiçek Günday, Asst. Prof.
Contact
cicek.gunday@istinye.edu.tr
+90 850 283 60 00
Hande Ateş
Contact
Orge Fatoş Demirtaş
study chair · Topkapi Liv Hospital
Mona Abualkas
study chair · Istinye University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion